Clinical Cardiology Alert – October 1, 2016
October 1, 2016
View Issues
-
Has the Benefit of Prophylactic ICDs Been Overestimated Among Those Suffering From Nonischemic Cardiomyopathy?
Prophylactic implantable cardioverter defibrillator implantation does not provide mortality benefit for nonischemic heart failure patients.
-
An Important Update in the Bare-metal vs. Drug-eluting Stent Debate
This randomized trial showed no difference between contemporary drug-eluting stents and bare-metal stents with regard to death and myocardial infarction, while drug-eluting stents demonstrated an advantage in both repeat revascularization and stent thrombosis at six years of follow-up.
-
Optimal Blood Pressure in Patients Presenting with Aortic Stenosis
A post-hoc analysis of patients suffering from mild to moderate aortic stenosis in a study of low-density lipoprotein cholesterol lowering showed that the optimal blood pressure for the best survival was 130-139/70-90 mmHg.
-
Hypothyroidism and PCI Outcomes
Hypothyroidism is common in patients undergoing percutaneous coronary interventions in a multivariate adjusted observational study was associated with worse long-term outcomes.
-
Heart Failure with Recovered Ejection Fraction: A Distinct Phenotype
Patients suffering from systolic heart failure who subsequently improve their ejection fraction experience a more favorable clinical course compared to those presenting with persistently reduced ejection fraction or heart failure with preserved ejection fraction.